The Food and Drug Administration has granted US market approval to Janssen Biotech/MorphoSys’ IL23 blocker...
Up To Date
Latest News
Swiss Novartis is about to receive the very first market approval (BLA) for a CAR-T cell cancer therapy...
French gut microbiome analysis specialist Enterome Bioscience SA and therapeutic nutrition company...
As part of a €5bn investment by 2025, the Free State of Bavaria will kick off two ambitious digital medicine...
At the opening ceremony for R&D, training and production buildings at Roche Penzberg, the Pharma giant said...
Belgian diagnostics company Biocartis Group NV and Singpore’s A*STAR ETPL have kicked off development of a...